Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Price, Quote & AI Analysis
Live TNXP stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Tonix Pharmaceuticals Holding Corp..
TradeVae provides AI-driven analysis and real-time market intelligence for Tonix Pharmaceuticals Holding Corp. (TNXP), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Tonix Pharmaceuticals Holding Corp.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Tonix Pharmaceuticals Holding Corp. Overview
Company information
Company Overview
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Tonix Pharmaceuticals Holding Corp. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...